We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Therapeutic drugs.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

Therapeutic drugs - List of Manufacturers, Suppliers, Companies and Products | IPROS GMS

Therapeutic drugs Product List

1～3 item / All 3 items

Displayed results
[Research Material] Global Market for Cancer Immunotherapy

[Research Material] Global Market for Cancer Immunotherapy

Global Market for Cancer Immunotherapy: Monoclonal Antibodies, Immune Checkpoint Inhibitors, Immune System Modulators, Cancer Vaccines, Lung Cancer, Breast Cancer ...

This research report (Global Cancer Immunotherapy Market) investigates and analyzes the current state and outlook for the global cancer immunotherapy market over the next five years. It includes information on the overview of the global cancer immunotherapy market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the cancer immunotherapy market include monoclonal antibodies, immune checkpoint inhibitors, immune system modulators, and cancer vaccines, while the segments by application cover lung cancer, breast cancer, colorectal cancer, melanoma, prostate cancer, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for cancer immunotherapy. The report also includes the market share of major companies in cancer immunotherapy, product and business overviews, and sales performance.

  • Other services
  • Therapeutic drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Bispecific Antibody Therapy

[Research Material] Global Market for Bispecific Antibody Therapy

World Market for Bispecific Antibody Therapy: Asymmetric Antibodies, Symmetric Antibodies, Fragment Antibodies, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Breast Cancer, Lung Cancer, Others

This research report (Global Bi-Specific Antibodies Therapy Market) investigates and analyzes the current status and outlook for the global market of bi-specific antibody therapy over the next five years. It includes information on the overview of the global bi-specific antibody therapy market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include asymmetric antibodies, symmetric antibodies, and fragment antibodies, while the segments by application focus on colorectal cancer, prostate cancer, cervical cancer, breast cancer, lung cancer, and others. The regional segments calculate the market size of bi-specific antibody therapy by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in bi-specific antibody therapy, product and business overviews, and sales performance.

  • Other services
  • Therapeutic drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global CAR-T Cell Therapy Market

[Market Report] Global CAR-T Cell Therapy Market

Global CAR-T Cell Therapy Market: A Pioneer in the Fight Against Cancer, Expected to Reach 5.9 Billion USD by 2031

The global CAR T cell therapy market is at the forefront of the fight against cancer, providing innovative and promising treatment options for patients. According to recent market reports, the global CAR T cell therapy market generated approximately $1.9 billion in revenue in 2022, and it is estimated to surge to $5.9 billion by 2031. This remarkable growth trajectory is projected to have a steady annual compound growth rate (CAGR) of 13.5% from 2023 to 2031. Chimeric Antigen Receptor (CAR) T cell therapy is a groundbreaking form of gene cell therapy that utilizes the body's T cells to target and eliminate cancer cells. Typically, the treatment involves three key steps: genetic modification of T cells, infusion of CAR T cells into the patient's body, and collection of T cells, all working together to combat cancer. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.

  • others
  • Therapeutic drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Related Categories of Therapeutic drugs

COPYRIGHT © 2001-2026 IPROS CORPORATION ALL RIGHTS RESERVED.